flumazenil ( anexate ) , a new benzodiazepine antagonist , was administered in doses of 0.2-0.4 mg to 40 patients for reversing the sedative effects of midazolam used as the sole induction agent in doses of 0.15-0.25 mg x kg-1 for short operations with a mean duration of 35 +/- 10 min .
C0016293
flumazenil
C0591091
anexate